Servet EBRİNC, Mustafa ISPİR, Ibrahim GUNDOGMUS, Murat KİYANCİCEK, Hakan KULLAKCİ, Ozgur MADEN, Ayhan ALGUL

Aripiprazole-induced sialorrhea responsive to amitriptyline treatment

Treatment compatibility is crucial for the psychiatric disorders. This can be provided with the low side effect profile of psychotropic drugs. Aripiprazole, a tolerable and safe antipsychotic, is used in the treatment of various psychiatric disorders. In the previous studies, sialorrhea was declared as a side effect of some antipsychotics. Furthermore, aripiprazole-related sialorrhea which was treated with diphenhydramine and trihexyphenidly, was reported in the literature. In our case, we discussed that aripiprazole-related sialorrhea developed in a male patient who treated with amitriptyline.

PDF

___

1. Freudenreich O, Beebe M, Goff DC. Clozapine-induced sialorrhea treated with sublingual ipratropium spray: a case series. J Clin Psychopharmacol. 2004;24(1):98-100. [CrossRef]
2. Praharaj SK, Arora M, Gandotra S. Clozapine-induced sialorrhea: pathophysiology and management strategies. Psychopharmacology (Berl). 2006;185(3):265-73. [CrossRef]
3. Ben-Aryeh H, Jungerman T, Szargel R, Klein E, Laufer D. Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biol Psychiatry. 1996;39(11):946-9. [CrossRef]
4. Harrison TS, Perry CM. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Drugs. 2004;64(15):1715-36. [CrossRef]
5. Greenaway M, Elbe D. Focus on aripiprazole: a review of its use in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry. 2009;18(3):250-60.
6. Kelly T, Lieberman DZ. The utility of low-dose Aripiprazole for the Treatment of Bipolar II and Bipolar NOS Depression. J Clin Psychopharmacol. 2017;37(1):99-101. [CrossRef]
7. Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology. 2003;28(8):1400-11. [CrossRef]
8. Praharaj SK, Jana AK, Sinha VK. Aripiprazole-induced sialorrhea. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(2):384-5. [CrossRef]
9. Kilinc S, Herguner A, Herguner S. Aripiprazole-Induced Sialorrhea Responsive to Diphenhydramine Treatment. J Child Adolesc Psychopharmacol. 2016;26(8):767-8. [CrossRef]
10. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, et al. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther. 2002;302(1):381-9. [CrossRef]
11. Freudenreich O. Drug-induced sialorrhea. Drugs Today (Barc). 2005;41(6):411-8. [CrossRef]
12. Goto T, Kato M, Matsumura Y, Omata N, Yoshida M, Watanabe K, et al. Scopolamine Ointment for Clozapine-Associated Sialorrhea: a case report. J Clin Psychopharmacol. 2017;37(1):106-7. [CrossRef]
13. Usta MG, Tufan AE, CUceloGlu EA. Diphenhydramine use in the treatment of risperidone-induced sialorrhea. J Child Adolesc Psychopharmacol. 2012;22(3):254-5. [CrossRef]
14. Praharaj SK, Arora M. Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea. Br J Clin Pharmacol. 2007;63(1):128-9. [CrossRef]
15. Yesilyurt S, Aras I, Altinbas K, Atagun MI, Kurt E. Pathophysiology of clozapine induced sialorrhea and current treatment choices. / Dusunen Adam The Journal of Psychiatry and Neurological Science. 2010:23(4):275-81. [CrossRef]